Copyright Reports & Markets. All rights reserved.

Global Autologous Cell Therapy Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Key Market Segments
    • 1.3 Players Covered
    • 1.4 Market Analysis by Type
      • 1.4.1 Global Autologous Cell Therapy Market Size Growth Rate by Type (2014-2025)
      • 1.4.2 Bone Marrow
      • 1.4.3 Epidermis
    • 1.5 Market by Application
      • 1.5.1 Global Autologous Cell Therapy Market Share by Application (2019-2025)
      • 1.5.2 Neurology
      • 1.5.3 Orthopedics
      • 1.5.4 Cancer
      • 1.5.5 Wound Healing
      • 1.5.6 Other
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Global Growth Trends

    • 2.1 Autologous Cell Therapy Market Size
    • 2.2 Autologous Cell Therapy Growth Trends by Regions
      • 2.2.1 Autologous Cell Therapy Market Size by Regions (2019-2025)
      • 2.2.2 Autologous Cell Therapy Market Share by Regions (2014-2019)
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers
      • 2.3.3 Market Challenges
      • 2.3.4 Porter’s Five Forces Analysis

    3 Market Share by Key Players

    • 3.1 Autologous Cell Therapy Market Size by by Players
      • 3.1.1 Global Autologous Cell Therapy Revenue by by Players (2014-2019)
      • 3.1.2 Global Autologous Cell Therapy Revenue Market Share by by Players (2014-2019)
      • 3.1.3 Global Autologous Cell Therapy Market Concentration Ratio (CR5 and HHI)
    • 3.2 Autologous Cell Therapy Key Players Head office and Area Served
    • 3.3 Key Players Autologous Cell Therapy Product/Solution/Service
    • 3.4 Date of Enter into Autologous Cell Therapy Market
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Breakdown Data by Type and Application

    • 4.1 Global Autologous Cell Therapy Market Size by Type (2014-2019)
    • 4.2 Global Autologous Cell Therapy Market Size by Application (2014-2019)

    5 North America

    • 5.1 North America Autologous Cell Therapy Market Size (2014-2019)
    • 5.2 Autologous Cell Therapy Key Players in North America
    • 5.3 North America Autologous Cell Therapy Market Size by Type
    • 5.4 North America Autologous Cell Therapy Market Size by Application

    6 Europe

    • 6.1 Europe Autologous Cell Therapy Market Size (2014-2019)
    • 6.2 Autologous Cell Therapy Key Players in Europe
    • 6.3 Europe Autologous Cell Therapy Market Size by Type
    • 6.4 Europe Autologous Cell Therapy Market Size by Application

    7 China

    • 7.1 China Autologous Cell Therapy Market Size (2014-2019)
    • 7.2 Autologous Cell Therapy Key Players in China
    • 7.3 China Autologous Cell Therapy Market Size by Type
    • 7.4 China Autologous Cell Therapy Market Size by Application

    8 Japan

    • 8.1 Japan Autologous Cell Therapy Market Size (2014-2019)
    • 8.2 Autologous Cell Therapy Key Players in Japan
    • 8.3 Japan Autologous Cell Therapy Market Size by Type
    • 8.4 Japan Autologous Cell Therapy Market Size by Application

    9 Southeast Asia

    • 9.1 Southeast Asia Autologous Cell Therapy Market Size (2014-2019)
    • 9.2 Autologous Cell Therapy Key Players in Southeast Asia
    • 9.3 Southeast Asia Autologous Cell Therapy Market Size by Type
    • 9.4 Southeast Asia Autologous Cell Therapy Market Size by Application

    10 India

    • 10.1 India Autologous Cell Therapy Market Size (2014-2019)
    • 10.2 Autologous Cell Therapy Key Players in India
    • 10.3 India Autologous Cell Therapy Market Size by Type
    • 10.4 India Autologous Cell Therapy Market Size by Application

    11 Central & South America

    • 11.1 Central & South America Autologous Cell Therapy Market Size (2014-2019)
    • 11.2 Autologous Cell Therapy Key Players in Central & South America
    • 11.3 Central & South America Autologous Cell Therapy Market Size by Type
    • 11.4 Central & South America Autologous Cell Therapy Market Size by Application

    12 International Players Profiles

    • 12.1 BioTime
      • 12.1.1 BioTime Company Details
      • 12.1.2 Company Description and Business Overview
      • 12.1.3 Autologous Cell Therapy Introduction
      • 12.1.4 BioTime Revenue in Autologous Cell Therapy Business (2014-2019))
      • 12.1.5 BioTime Recent Development
    • 12.2 Pharmicell
      • 12.2.1 Pharmicell Company Details
      • 12.2.2 Company Description and Business Overview
      • 12.2.3 Autologous Cell Therapy Introduction
      • 12.2.4 Pharmicell Revenue in Autologous Cell Therapy Business (2014-2019)
      • 12.2.5 Pharmicell Recent Development
    • 12.3 BrainStorm Cell Therapeutics
      • 12.3.1 BrainStorm Cell Therapeutics Company Details
      • 12.3.2 Company Description and Business Overview
      • 12.3.3 Autologous Cell Therapy Introduction
      • 12.3.4 BrainStorm Cell Therapeutics Revenue in Autologous Cell Therapy Business (2014-2019)
      • 12.3.5 BrainStorm Cell Therapeutics Recent Development
    • 12.4 Opexa Therapeutics
      • 12.4.1 Opexa Therapeutics Company Details
      • 12.4.2 Company Description and Business Overview
      • 12.4.3 Autologous Cell Therapy Introduction
      • 12.4.4 Opexa Therapeutics Revenue in Autologous Cell Therapy Business (2014-2019)
      • 12.4.5 Opexa Therapeutics Recent Development
    • 12.5 Vericel Corporation
      • 12.5.1 Vericel Corporation Company Details
      • 12.5.2 Company Description and Business Overview
      • 12.5.3 Autologous Cell Therapy Introduction
      • 12.5.4 Vericel Corporation Revenue in Autologous Cell Therapy Business (2014-2019)
      • 12.5.5 Vericel Corporation Recent Development
    • 12.6 Regeneus
      • 12.6.1 Regeneus Company Details
      • 12.6.2 Company Description and Business Overview
      • 12.6.3 Autologous Cell Therapy Introduction
      • 12.6.4 Regeneus Revenue in Autologous Cell Therapy Business (2014-2019)
      • 12.6.5 Regeneus Recent Development

    13 Market Forecast 2019-2025

    • 13.1 Market Size Forecast by Product (2019-2025)
    • 13.2 Market Size Forecast by Application (2019-2025)
    • 13.3 Market Size Forecast by Regions
    • 13.4 North America
    • 13.5 Europe
    • 13.6 China
    • 13.7 Japan
    • 13.8 Southeast Asia
    • 13.9 India
    • 13.10 Central & South America

    14 Analyst's Viewpoints/Conclusions

      15 Appendix

      • 15.1 Research Methodology
        • 15.1.1 Methodology/Research Approach
          • 15.1.1.1 Research Programs/Design
          • 15.1.1.2 Market Size Estimation
          • 15.1.1.3 Market Breakdown and Data Triangulation
        • 15.1.2 Data Source
          • 15.1.2.1 Secondary Sources
          • 15.1.2.2 Primary Sources
      • 15.2 Disclaimer

      Autologous cell therapy refers to the injection or delivery of human tissue or cells to the same person to treat pathological conditions. For the same purpose, the stem cells are taken out of the patient, harvested, cultured, and transplanted again to the same person. The purpose of this method is to reduce the chance of rejecting treatment in the body. In addition, autologous cell therapy does not require immunosuppression.
      In 2018, the global Autologous Cell Therapy market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

      This report focuses on the global Autologous Cell Therapy status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Autologous Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

      The key players covered in this study
      BioTime
      Pharmicell
      BrainStorm Cell Therapeutics
      Opexa Therapeutics
      Vericel Corporation
      Regeneus
      ...

      Market segment by Type, the product can be split into
      Bone Marrow
      Epidermis

      Market segment by Application, split into
      Neurology
      Orthopedics
      Cancer
      Wound Healing
      Other

      Market segment by Regions/Countries, this report covers
      North America
      Europe
      China
      Japan
      Southeast Asia
      India
      Central & South America

      The study objectives of this report are:
      To analyze global Autologous Cell Therapy status, future forecast, growth opportunity, key market and key players.
      To present the Autologous Cell Therapy development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
      To strategically profile the key players and comprehensively analyze their development plan and strategies.
      To define, describe and forecast the market by product type, market and key regions.

      In this study, the years considered to estimate the market size of Autologous Cell Therapy are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025
      For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

      Buy now